Archive for the ‘Breast Center Pathology’ Category
Fibroadenoma cross section
Fibroadenomas are common in women of all ages, but we start seeing them as biopsies in younger, reproductive aged women. Often these are felt as breast lumps, and are brought to the attention of family physicians and OB-Gyns. These breast tumors are curious because they are formed from two elements unlike other breast lesions or breast disease. The fibroadenoma has both stromal and epithelial elements that are integral in its formation. Most of breast disease, in contrast, is formed by one element, and that is the epithelium or lining of the breast ducts.
Fibroadenoma with large calcifications (dark red-purple)
Fibroadenomas have a fibrous stromal framework that surrounds slit like spaces lined by ductal epithelium. There are several variations of the epithelial growth pattern within the fibroadenoma, but always there are the two elements. In younger women the stroma is often looser and may have a bluish “juicy” appearance under the microscope. I often use the term “succulent” to describe these changes. As the fibroadenoma ages, the fibrous tissue becomes denser and calcifications may occur.
The fibroadenoma has a characteristic mammographic appearance, and the expert radiologist can often be sure of the diagnosis by its image characteristics. However, when there is any doubt about the exact diagnosis, a needle core biopsy is recommended. As you can imagine, until the lesion is sampled by a biopsy, you cannot be certain about the exact nature of the lesion that was felt originally, or found on mammogram. Biopsy of the lesion can bring relief from uncertainty, and allow for treatment decision planning based on facts.
As a general statement, fibroadenomas are benign and stay benign. These lesions may occur in sequence, meaning a new one may form after one has been removed. Both typically are very benign in appearance. Multiple fibroadenoma may occur at the same time in the same breast or both breasts. Only rarely is the fibroadenoma associated with malignant disease, but it does occur. The good news is that if this happens, the mammographic image changes, and needle core biopsy is recommended in this situation for diagnosis and clarification.
Treatment options are best discussed with your physician. In the majority of cases, the woman may decide to “live with” the fibroadenoma and leave it alone, or have it excised.
When a pathologist looks at a breast needle core biopsy, he or she looks over the entire prepared tissue biopsy to survey what is normal and what is abnormal. At low microscopic power, it is like flying over land to look at its various aspects, whether it is meadows, plowed fields, a city or town, or a mountain. This first view is to get an idea of what is normal and abnormal, and what the mammographer saw on mammogram originally to warrant doing the biopsy.
As the pathologist “flies over” the tissue on the slide, in this case, he sees abnormally enlarged ducts that are many times bigger than normal. This requires a closer look, and so the pathologist switches to a higher power lens and focuses on these enlarged ducts.
As you can see, here are clustered large ducts that are filled with many cells. This cellular proliferation or growth remains in the duct or tubule, causing it to expand and enlarge. These malignant cells are all abnormal, and there are no layers. Normal ducts are lined by two cell layers, and the outer cells are different from those in the inner layer. Please refer to the blog on normal breast in this Show Me series.
Now what about in situ? What does that mean? In situ means in place; the cancer cells are growing in place or inside the duct: non-invasive and in place. When the malignant cells are growing inside the duct, it is called Ductal Carcinoma In Situ—DCIS. (Once the cells start to grow outside the duct, they are invading adjacent tissue and are invasive.)
We should remember that malignant cells in general do not have a feed-back regulatory function to stop growth. Malignant cells grow and multiply and don’t stop this process. There is no self control or stopping mechanism. So with DCIS, malignant cells grow “out of control” inside the ducts. The malignant cells grow down the duct system toward the nipple. This is a non-invasive growth because these abnormal cells stay inside the duct, and because of inside-only growth, there is no invasion by definition.
What I am getting ready to tell you is hard to understand and hard to believe. Because the malignant cells stay inside the ducts, and often grow toward the nipple, the extent of the disease may be such that a larger excision is required than for an invasive tumor. The non-invasive disease can grow unchallenged down the duct toward the nipple; without resistance, DCIS can grow over considerable distances sometimes. Here is the hard part: because of its unrestrained growth toward the nipple, non-invasive DCIS may require a larger excision or mastectomy while an invasive tumor is often successfully treated with lumpectomy. It all has to do with extent of disease, and the non-invasive lesion can require more tissue to be removed (bigger surgery) than a purely invasive tumor.
The purpose of this new blog is to discuss activities behind the scenes in an anatomic pathology laboratory in a community hospital setting. This laboratory has been involved in the evolution of changes that have occurred since our comprehensive breast center was established in 1996. Patients know that their biopsies and larger resections will be handled in an optimal manner when their specimens come to our lab. But few patients have ever met their pathologist or talked with them about their diagnosis and how it was made. So this website, www.breastpath.com, and this blog is for women who want to know more about their pathology report, and how the diagnosis was made. This blog also allows you to converse directly with a pathologist who has been deeply involved in a comprehensive breast center for 14 years and practicing for 37 years.
